Ginkgo Bioworks and Synplogen partner in global DNA manufacturing in Japan

Ginkgo Bioworks and Synplogen, a synthetic biology startup spun out of Kobe University’s Graduate School of Science, Technology and Innovation that provides custom DNA synthesis and Gene Therapy Biofoundry services, have entered into a non-binding Memorandum of Understanding to accelerate the global development of DNA manufacturing and gene therapy platform services in Japan. Ginkgo and Synplogen will explore global business collaboration opportunities for DNA manufacturing. Synplogen’s OGAB DNA synthesis services have the ability to synthesize DNA of various lengths up to 100 kbp. OGAB is also capable of complex DNA synthesis, with features such as a high/low guanine-cytosine content and repeat sequences. Furthermore, Ginkgo and Synplogen will work to extend the reach of Ginkgo’s gene therapy services in Japan. Synplogen plans to collaborate by offering business development and marketing support to connect Ginkgo’s services with Japanese biotechnology and pharmaceutical companies.